Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity.

Digestive Diseases and Sciences
Ira Shafran, Patricia Burgunder

Abstract

Enteric bacteria are thought to contribute to the pathogenesis of Crohn's disease, and antibiotics may be an effective therapy. This study examines the efficacy of the nonsystemic (<0.4% absorbed) antibiotic rifaximin for inducing remission in patients with Crohn's disease. Data from charts of patients with Crohn's disease who received rifaximin between 2001 and 2005 and had a Crohn's disease activity index score > or =220 at the time of rifaximin initiation were analyzed. The use of concomitant medications (e.g., steroids, anti-inflammatory agents) was allowed. In the 68 patient charts analyzed, the median duration of rifaximin treatment was 16.6 weeks, and the majority of patients (94%) received rifaximin 600 mg/day. Eighteen patients (26%) received rifaximin monotherapy, and 31 patients (46%) received concomitant steroids. The median baseline Crohn's disease activity index score at the time of rifaximin initiation was 265 (range, 220-460), and the mean duration of Crohn's disease was 17 years (range, 1-50 years). Crohn's disease remission occurred in 65% of patients. A 70% remission rate was achieved in patients who did not receive steroids, versus 58% in patients who received steroids. Clinical improvements continued 4 mont...Continue Reading

References

Jan 1, 1978·Scandinavian Journal of Gastroenterology·P BlichfeldtE Gjone
May 1, 1992·Annals of Surgery·J L CameronT M Bayless
Feb 1, 1985·Diseases of the Colon and Rectum·N S AmbroseJ E Lennard-Jones
Jun 10, 2000·Alimentary Pharmacology & Therapeutics·K LeiperJ M Rhodes
Jul 18, 2000·Antimicrobial Agents and Chemotherapy·Z D JiangH Dupont
Feb 12, 2002·Inflammatory Bowel Diseases·George L ArnoldWilliam J Mook
Jul 10, 2002·Gastroenterology·A Hillary SteinhartGordon R Greenberg
Aug 9, 2002·The New England Journal of Medicine·Daniel K Podolsky
Jun 18, 2003·The American Journal of Gastroenterology·Robert SteffenHerbert L DuPont
Apr 28, 2005·Chemotherapy·Z D Jiang, H L DuPont
May 10, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Faten N AberraJames D Lewis
May 18, 2005·Annals of Internal Medicine·Herbert L DuPontFrancisco Martinez-Sandoval
Aug 9, 2005·Current Medical Research and Opinion·Ira Shafran, Lorin K Johnson
May 31, 2006·World Journal of Gastroenterology : WJG·Paolo GionchettiMassimo Campieri
Jul 5, 2006·Nature Clinical Practice. Gastroenterology & Hepatology·R Balfour Sartor
Aug 29, 2006·World Journal of Gastroenterology : WJG·Carsten Büning, Herbert Lochs
Dec 29, 2007·The Journal of Pathology·D J B Marks, A W Segal
Sep 18, 2008·The American Journal of Gastroenterology·Ira Shafran, Patricia Burgunder

❮ Previous
Next ❯

Citations

Feb 7, 2013·Best Practice & Research. Clinical Gastroenterology·Charles RandallGregory Constantine
Dec 11, 2013·Cellular Immunology·Sean BandzarManu O Platt
Feb 10, 2011·Nature Reviews. Gastroenterology & Hepatology·Si Ming ManHazel M Mitchell
Sep 2, 2011·The New England Journal of Medicine·Alex F HerreraFrancisco M Marty
Apr 12, 2013·Inflammatory Bowel Diseases·Junichi IwamotoYasushi Matsuzaki
Jul 16, 2010·The Journal of Pharmacology and Experimental Therapeutics·Jie ChengFrank J Gonzalez
Dec 20, 2011·World Journal of Gastroenterology : WJG·Mario Guslandi
Feb 16, 2010·Digestive Diseases and Sciences·A S Day, R B Gearry
Apr 30, 2010·Digestive Diseases and Sciences·Mario Guslandi
Jun 15, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·Ggg DondersD Rezeberga
Jan 7, 2015·Pharmacology & Therapeutics·Giovanni CammarotaDiego Currò
Nov 2, 2013·Therapeutic Advances in Chronic Disease·Antonio Tursi
Jun 6, 2018·Expert Opinion on Investigational Drugs·Loris R LopetusoAntonio Gasbarrini
Oct 22, 2011·Expert Review of Clinical Immunology·William ChamberlinJordana Campbell
Aug 21, 2014·Postgraduate Medicine·David H Kerman, Amar R Deshpande
Apr 7, 2019·Mucosal Immunology·Mei Lan ChenMark S Sundrud
Aug 23, 2016·World Journal of Gastroenterology : WJG·Rani H ShaytoAla I Sharara
Nov 10, 2017·Mediators of Inflammation·Danilo PagliariRossella Cianci
Jan 19, 2019·Anti-cancer Agents in Medicinal Chemistry·Jihene Elloumi-MseddiSami Aifa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The Journal of Pharmacology and Experimental Therapeutics
Xiaochao MaFrank J Gonzalez
Gastroenterology
Cosimo PranteraRetic Study Group (Rifaximin-Eir Treatment in Crohn's Disease)
The New England Journal of Medicine
Nathan M BassWilliam P Forbes
© 2021 Meta ULC. All rights reserved